Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
COVID-19 infection causes a hypersensitive immune reaction and widespread inflammation in various organs of the body, especially through cytokines in the lungs. This cytokine-mediated widespread inflammation can also affect the parathyroid glands, resulting in impaired parathyroid secretion. Researchers evaluated the levels of parathyroid hormone, calcium, phosphorus, and alkaline phosphatase in patients hospitalized for COVID-19 infection. Researchers excluded patients on intensive care therapy and patients with known parathyroid disease. The researchers examined the association of parathyroid hormone secretion with COVID-19 disease, white blood cells, neutrophil / lymphocyte ratio, C reactive protein, fibrinogen, procalcitonin, ferritin, and D-dimer in these patients. The researchers compared the parathyroid hormone level of healthy people without COVID-19 infection and known parathyroid disease with the parathyroid hormone level of Covid-19 patients.
Description: In the study, serum parathyroid hormone results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of parathyroid hormone between groups Time: 90 daysDescription: In the study, serum calcium results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of calcium between groups Time: 90 daysDescription: In the study, serum phosphorus results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of phosphorus between groups Time: 90 daysDescription: In the study, serum alkaline phosphatase results of the Covid patient group and non-Covid control groups were recorded and compared statistically.
Measure: Comparison of alkaline phosphatase between groups Time: 90 daysDescription: In the study, serum WBC results were recorded in Covid 19 patient groups.
Measure: White blood cells (WBC) results of Covid 19 patient group Time: 90 daysDescription: In the study, serum N/LO results were recorded in Covid 19 patient groups.
Measure: Neutrophil / lymphocyte ratio (N/LO) results of Covid 19 patient group Time: 90 daysDescription: In the study, serum CRP results were recorded in Covid 19 patient groups.
Measure: C-reactive protein (CRP) results of Covid 19 patient group Time: 90 daysDescription: In the study, serum fibrinogen results were recorded in Covid 19 patient groups.
Measure: Fibrinogen results of Covid 19 patient group Time: 90 daysDescription: In the study, serum procalcitonin results were recorded in Covid 19 patient groups.
Measure: Procalcitonin results of Covid 19 patient group Time: 90 daysDescription: In the study, serum ferritin results were recorded in Covid 19 patient groups.
Measure: Ferritin results of Covid 19 patient group Time: 90 daysDescription: In the study, serum D-dimer results were recorded in Covid 19 patient groups.
Measure: D-dimer results of Covid 19 patient group Time: 90 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports